These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

404 related articles for article (PubMed ID: 9109537)

  • 1. 4-Hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease.
    Sayre LM; Zelasko DA; Harris PL; Perry G; Salomon RG; Smith MA
    J Neurochem; 1997 May; 68(5):2092-7. PubMed ID: 9109537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-bound acrolein: a novel marker of oxidative stress in Alzheimer's disease.
    Calingasan NY; Uchida K; Gibson GE
    J Neurochem; 1999 Feb; 72(2):751-6. PubMed ID: 9930749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4.
    Montine KS; Olson SJ; Amarnath V; Whetsell WO; Graham DG; Montine TJ
    Am J Pathol; 1997 Feb; 150(2):437-43. PubMed ID: 9033259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoperoxidation is selectively involved in progressive supranuclear palsy.
    Odetti P; Garibaldi S; Norese R; Angelini G; Marinelli L; Valentini S; Menini S; Traverso N; Zaccheo D; Siedlak S; Perry G; Smith MA; Tabaton M
    J Neuropathol Exp Neurol; 2000 May; 59(5):393-7. PubMed ID: 10888369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical investigation of the brain of aged dogs. I. Detection of neurofibrillary tangles and of 4-hydroxynonenal protein, an oxidative damage product, in senile plaques.
    Papaioannou N; Tooten PC; van Ederen AM; Bohl JR; Rofina J; Tsangaris T; Gruys E
    Amyloid; 2001 Mar; 8(1):11-21. PubMed ID: 11293821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-hydroxy-2-nonenal pyrrole adducts in human neurodegenerative disease.
    Montine KS; Kim PJ; Olson SJ; Markesbery WR; Montine TJ
    J Neuropathol Exp Neurol; 1997 Aug; 56(8):866-71. PubMed ID: 9258256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unaltered brain levels of 1,N2-propanodeoxyguanosine adducts of trans-4-hydroxy-2-nonenal in Alzheimer's disease.
    Götz ME; Wacker M; Luckhaus C; Wanek P; Tatschner T; Jellinger K; Leblhuber F; Ransmayr G; Riederer P; Eder E
    Neurosci Lett; 2002 May; 324(1):49-52. PubMed ID: 11983292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crotonaldehyde accumulates in glial cells of Alzheimer's disease brain.
    Kawaguchi-Niida M; Shibata N; Morikawa S; Uchida K; Yamamoto T; Sawada T; Kobayashi M
    Acta Neuropathol; 2006 May; 111(5):422-9. PubMed ID: 16538519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.
    Sultana R; Butterfield DA
    Neurochem Res; 2004 Dec; 29(12):2215-20. PubMed ID: 15672542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer's disease.
    Völkel W; Sicilia T; Pähler A; Gsell W; Tatschner T; Jellinger K; Leblhuber F; Riederer P; Lutz WK; Götz ME
    Neurochem Int; 2006 Jun; 48(8):679-86. PubMed ID: 16483694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated levels of 4-hydroxynonenal-histidine Michael adduct in the hippocampi of patients with Alzheimer's disease.
    Fukuda M; Kanou F; Shimada N; Sawabe M; Saito Y; Murayama S; Hashimoto M; Maruyama N; Ishigami A
    Biomed Res; 2009 Aug; 30(4):227-33. PubMed ID: 19729853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of reducible 4-hydroxynonenal adduct immunoreactivity in Alzheimer disease is associated with APOE genotype.
    Montine KS; Reich E; Neely MD; Sidell KR; Olson SJ; Markesbery WR; Montine TJ
    J Neuropathol Exp Neurol; 1998 May; 57(5):415-25. PubMed ID: 9596412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HNE-modified proteins in Down syndrome: Involvement in development of Alzheimer disease neuropathology.
    Barone E; Head E; Butterfield DA; Perluigi M
    Free Radic Biol Med; 2017 Oct; 111():262-269. PubMed ID: 27838436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxidative stress hypothesis in Alzheimer's disease.
    Markesbery WR
    Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence that transmitter-containing dystrophic neurites precede paired helical filament and Alz-50 formation within senile plaques in the amygdala of nondemented elderly and patients with Alzheimer's disease.
    Benzing WC; Ikonomovic MD; Brady DR; Mufson EJ; Armstrong DM
    J Comp Neurol; 1993 Aug; 334(2):176-91. PubMed ID: 7690048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective PrP-like protein, doppel immunoreactivity in dystrophic neurites of senile plaques in Alzheimer's disease.
    Ferrer I; Freixas M; Blanco R; Carmona M; Puig B
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):329-37. PubMed ID: 15305978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative modification of lipoic acid by HNE in Alzheimer disease brain.
    Hardas SS; Sultana R; Clark AM; Beckett TL; Szweda LI; Murphy MP; Butterfield DA
    Redox Biol; 2013; 1(1):80-5. PubMed ID: 24024140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-hydroxynonenal and neurodegenerative diseases.
    Zarkovic K
    Mol Aspects Med; 2003; 24(4-5):293-303. PubMed ID: 12893007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid beta-peptide.
    Mark RJ; Lovell MA; Markesbery WR; Uchida K; Mattson MP
    J Neurochem; 1997 Jan; 68(1):255-64. PubMed ID: 8978733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein E is present in hippocampal neurons without neurofibrillary tangles in Alzheimer's disease and in age-matched controls.
    Han SH; Hulette C; Saunders AM; Einstein G; Pericak-Vance M; Strittmatter WJ; Roses AD; Schmechel DE
    Exp Neurol; 1994 Jul; 128(1):13-26. PubMed ID: 8070517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.